Profil
Debra Segal is currently the Head of Regulatory Affairs at Dianthus Therapeutics, Inc. Prior to her current position, she served as the Senior Vice President of Regulatory Affairs at Scholar Rock, Inc. from 2021 to 2023.
Aktive Positionen von Debra Segal
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | General Counsel | 11.09.2023 |
Ehemalige bekannte Positionen von Debra Segal
| Unternehmen | Position | Ende |
|---|---|---|
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | General Counsel | 01.03.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
